Generic drug
Methylene blue price, strengths & recalls
Methylene blue has no weekly pharmacy acquisition cost. 9 manufacturers make it. 2 recalls are ongoing. Its official label last changed on February 5, 2025.
2 open recallsGenericMethylene blue price by strength
What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 5 mg/mL, 10 mL injection | Not priced this week | |||
| 10 mg/mL, 10 mL injection | Not priced this week | |||
| 10 mg/mL oral solution | Not priced this week | |||
| 10 mg/mL, 2 mL prefilled syringe | Not priced this week | |||
Supply status: shortages & recalls
Recalls
Showing the 6 most relevant of 13 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Methylene blue
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use METHYLENE BLUE INJECTION safely and effectively. See full prescribing information for METHYLENE BLUE INJECTION.METHYLENE BLUE injection, for intravenous useInitial U.S. Approval: 2016
WARNING: SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC DRUGS AND OPIOIDS
Methylene blue injection may cause serious or fatal serotonergic syndrome when used in combination with serotonergic drugs and opioids. Avoid concomitant use of methylene blue injection with selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs) and opioids [see Warnings and Precautions (5.1) and Drug Interactions (7.1)].
WARNING: SEROTONIN SYNDROME WITH CONCOMITANT USE OF SEROTONERGIC DRUGS AND OPIOIDS
See full prescribing information for complete boxed warning.
Methylene blue injection may cause serious or fatal serotonergic syndrome when used in combination with serotonergic drugs and opioids. Avoid concomitant use of methylene blue injection with selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors (MAOIs) and opioids. (5.1, 7.1)
Recent major changes (as listed on the label)
Boxed Warning | 11/2023 |
Warnings and Precautions (5) | 11/2023 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 5 approved generic applications on the market
Methylene blue questions
Is methylene blue in shortage?
No shortage is reported for methylene blue right now. We check the national shortage list every day.
Has methylene blue been recalled?
13 recalls on record, 2 ongoing. Recalls name specific lots - check yours.
When did the methylene blue label last change?
The official label was last updated on February 5, 2025 (version 8). See what changed.
Talk about methylene blue
No comments yet. Questions, tips, what worked for you - start the conversation.